Door rotates again at pot stock Elixinol with return of the founder as chair

by Newsfeed


Nine months after he resigned as CEO and three months after quitting as chief innovation officer, Elixinol (ASX:EXL) founder Paul Benhaim is back as chairman.

He replaces Andrew Duff, who chaired the company from its 2018 ASX listing, and Greg Ellory who was appointed last year is being replaced by former Swisse Wellness CEO Oliver Horn.

Duff wrote in the annual report, released last week, that the appointment of current CEO Stratos Karousos in July last year “underpins Elixinol Global’s evolution from a founder-led company to a business focused on building Elixinol into a dynamic and trusted global brand with the operational processes and people to underpin this”.

 

Straitened circumstances

The company Benhaim leads today is a slightly different beast under different pressures to the one he…



Read Full Article Here

#1 trusted top selling CBD

You may also like